Listeria monocytogenes requires cellular respiration for NAD+ regeneration and pathogenesis

  1. Rafael Rivera-Lugo
  2. David Deng
  3. Andrea Anaya-Sanchez
  4. Sara Tejedor-Sanz
  5. Eugene Tang
  6. Valeria M Reyes Ruiz
  7. Hans B Smith
  8. Denis V Titov
  9. John Demian Sauer
  10. Eric P Skaar
  11. Caroline M Ajo-Franklin
  12. Daniel A Portnoy
  13. Samuel H Light  Is a corresponding author
  1. University of California, Berkeley, United States
  2. Rice University, United States
  3. Vanderbilt University Medical Center, United States
  4. University of Wisconsin-Madison, United States
  5. University of Chicago, United States

Abstract

Cellular respiration is essential for multiple bacterial pathogens and a validated antibiotic target. In addition to driving oxidative phosphorylation, bacterial respiration has a variety of ancillary functions that obscure its contribution to pathogenesis. We find here that the intracellular pathogen Listeria monocytogenes encodes two respiratory pathways which are partially functionally redundant and indispensable for pathogenesis. Loss of respiration decreased NAD+ regeneration, but this could be specifically reversed by heterologous expression of a water-forming NADH oxidase (NOX). NOX expression fully rescued intracellular growth defects and increased L. monocytogenes loads >1,000-fold in a mouse infection model. Consistent with NAD+ regeneration maintaining L. monocytogenes viability and enabling immune evasion, a respiration-deficient strain exhibited elevated bacteriolysis within the host cytosol and NOX expression rescued this phenotype. These studies show that NAD+ regeneration represents a major role of L. monocytogenes respiration and highlight the nuanced relationship between bacterial metabolism, physiology, and pathogenesis.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Rafael Rivera-Lugo

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2346-2297
  2. David Deng

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  3. Andrea Anaya-Sanchez

    Graduate Group in Microbiology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  4. Sara Tejedor-Sanz

    Department of Biosciences, Rice University, Houston, United States
    Competing interests
    No competing interests declared.
  5. Eugene Tang

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  6. Valeria M Reyes Ruiz

    Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  7. Hans B Smith

    Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  8. Denis V Titov

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    Denis V Titov, is a co-inventor on a filed patent describing the use of NOX. (US Patent App. 15/749,218).
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5677-0651
  9. John Demian Sauer

    Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9367-794X
  10. Eric P Skaar

    Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  11. Caroline M Ajo-Franklin

    Department of Biosciences, Rice University, Houston, United States
    Competing interests
    No competing interests declared.
  12. Daniel A Portnoy

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  13. Samuel H Light

    Department of Microbiology, University of Chicago, Chicago, United States
    For correspondence
    samlight@uchicago.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8074-1348

Funding

National Institutes of Health (T32GM007215)

  • Hans B Smith

Searle Scholars Program

  • Samuel H Light

National Institutes of Health (R01AI137070)

  • John Demian Sauer

National Institutes of Health (R01AI073843)

  • Eric P Skaar

National Institutes of Health (R01AI073843)

  • Eric P Skaar

National Institutes of Health (1P01AI063302)

  • Daniel A Portnoy

National Institutes of Health (1R01AI27655)

  • Daniel A Portnoy

National Institutes of Health (K22AI144031)

  • Samuel H Light

National Academies of Sciences, Engineering, and Medicine (Ford Foundation Fellowship)

  • Rafael Rivera-Lugo

University of California (Dissertation-Year Fellowship)

  • Rafael Rivera-Lugo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Sophie Helaine, Harvard Medical School, United States

Ethics

Animal experimentation: All animal work was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Protocols were reviewed and approved by the Animal Care and Use Committee at the University of California, Berkeley (AUP 2016-05-8811).

Version history

  1. Received: November 9, 2021
  2. Preprint posted: November 25, 2021 (view preprint)
  3. Accepted: April 4, 2022
  4. Accepted Manuscript published: April 5, 2022 (version 1)
  5. Version of Record published: May 11, 2022 (version 2)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,370
    Page views
  • 344
    Downloads
  • 14
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rafael Rivera-Lugo
  2. David Deng
  3. Andrea Anaya-Sanchez
  4. Sara Tejedor-Sanz
  5. Eugene Tang
  6. Valeria M Reyes Ruiz
  7. Hans B Smith
  8. Denis V Titov
  9. John Demian Sauer
  10. Eric P Skaar
  11. Caroline M Ajo-Franklin
  12. Daniel A Portnoy
  13. Samuel H Light
(2022)
Listeria monocytogenes requires cellular respiration for NAD+ regeneration and pathogenesis
eLife 11:e75424.
https://doi.org/10.7554/eLife.75424

Share this article

https://doi.org/10.7554/eLife.75424

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Karolina Honzejkova, Dalibor Kosek ... Tomas Obsil
    Research Article

    Apoptosis signal-regulating kinase 1 (ASK1) is a crucial stress sensor, directing cells toward apoptosis, differentiation, and senescence via the p38 and JNK signaling pathways. ASK1 dysregulation has been associated with cancer and inflammatory, cardiovascular, and neurodegenerative diseases, among others. However, our limited knowledge of the underlying structural mechanism of ASK1 regulation hampers our ability to target this member of the MAP3K protein family towards developing therapeutic interventions for these disorders. Nevertheless, as a multidomain Ser/Thr protein kinase, ASK1 is regulated by a complex mechanism involving dimerization and interactions with several other proteins, including thioredoxin 1 (TRX1). Thus, the present study aims at structurally characterizing ASK1 and its complex with TRX1 using several biophysical techniques. As shown by cryo-EM analysis, in a state close to its active form, ASK1 is a compact and asymmetric dimer, which enables extensive interdomain and interchain interactions. These interactions stabilize the active conformation of the ASK1 kinase domain. In turn, TRX1 functions as a negative allosteric effector of ASK1, modifying the structure of the TRX1-binding domain and changing its interaction with the tetratricopeptide repeats domain. Consequently, TRX1 reduces access to the activation segment of the kinase domain. Overall, our findings not only clarify the role of ASK1 dimerization and inter-domain contacts but also provide key mechanistic insights into its regulation, thereby highlighting the potential of ASK1 protein-protein interactions as targets for anti-inflammatory therapy.

    1. Biochemistry and Chemical Biology
    Jake W Anderson, David Vaisar ... Natalie G Ahn
    Research Article

    Activation of the extracellular signal-regulated kinase-2 (ERK2) by phosphorylation has been shown to involve changes in protein dynamics, as determined by hydrogen-deuterium exchange mass spectrometry (HDX-MS) and NMR relaxation dispersion measurements. These can be described by a global exchange between two conformational states of the active kinase, named ‘L’ and ‘R,’ where R is associated with a catalytically productive ATP-binding mode. An ATP-competitive ERK1/2 inhibitor, Vertex-11e, has properties of conformation selection for the R-state, revealing movements of the activation loop that are allosterically coupled to the kinase active site. However, the features of inhibitors important for R-state selection are unknown. Here, we survey a panel of ATP-competitive ERK inhibitors using HDX-MS and NMR and identify 14 new molecules with properties of R-state selection. They reveal effects propagated to distal regions in the P+1 and helix αF segments surrounding the activation loop, as well as helix αL16. Crystal structures of inhibitor complexes with ERK2 reveal systematic shifts in the Gly loop and helix αC, mediated by a Tyr-Tyr ring stacking interaction and the conserved Lys-Glu salt bridge. The findings suggest a model for the R-state involving small movements in the N-lobe that promote compactness within the kinase active site and alter mobility surrounding the activation loop. Such properties of conformation selection might be exploited to modulate the protein docking interface used by ERK substrates and effectors.